Viridian Therapeutics, Inc.\DEVRDNEarnings & Financial Report
Nasdaq · Health Care · Pharmaceutical Preparations
Viridian Therapeutics is a clinical-stage biotechnology firm developing novel disease-modifying therapies for rare, serious autoimmune and inflammatory diseases. Its lead pipeline candidate targets thyroid eye disease, a debilitating orbital disorder, with primary market focus on North America and Europe.